Wyniki wyszukiwania dla: ACRIDINONE DERIVATIVES

• Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism and Cellular Response

  Publikacja

  • M. Pawłowska
  • A. Kwaśniewska
  • Z. Mazerska
  • E. Augustin

  - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - Rok 2020

  Activity modulation of drug metabolism enzymes can change the biotransformation of chemotherapeutics and cellular responses induced by them. As a result, drug-drug interactions can be modified. Acridinone derivatives, represented here by C-1305 and C-1311, are potent anticancer drugs. Previous studies in non-cellular systems showed that they are mechanism-based inhibitors of cytochrome P4503A4 and undergo glucuronidation via UDP-glucuronosyltranspherase...

  Pełny tekst do pobrania w portalu

• Modulation of UDP-glucuronidation by acridinone antitumor agents C-1305 and C-1311 in HepG2 and HT29 cell lines, despite slight impact in noncellular systems.

  Publikacja

  • A. Bejrowska
  • M. Pawłowska
  • A. Mróz
  • Z. Mazerska

  - Pharmacological Reports - Rok 2018

  Background Among the studied antitumor acridinone derivatives developed in our laboratory, 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) exhibited cytotoxic and antitumor properties against several cancer types and were selected to be evaluated in preclinical and early-phase clinical trials. In the present work, we investigated the impact of C-1305...

  Pełny tekst do pobrania w serwisie zewnętrznym